These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23178618)

  • 21. Changes with aging in gastric biomarkers levels and in biochemical factors associated with
    Shan JH; Bai XJ; Han LL; Yuan Y; Sun XF
    World J Gastroenterol; 2017 Aug; 23(32):5945-5953. PubMed ID: 28932086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of Helicobacter pylori eradication on body mass index and dyspeptic symptoms.
    Suto H; Yamazaki Y; Yoshida I; Yamakawa A; Ohtani M; Ito Y; Kuriyama M; Kato T; Azuma T
    Digestion; 2009; 79(4):235-42. PubMed ID: 19401613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
    Gisbert JP; Boixeda D; Al-Mostafa A; Vila T; de Rafael L; Alvarez Baleriola I; de Argila CM; Abraira V
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test.
    Gong Y; Wei W; Yuan Y
    Diagn Microbiol Infect Dis; 2014 Dec; 80(4):316-20. PubMed ID: 25284372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pepsinogen and gastrin in the noninvasive diagnosis of gastric atrophy. A case-control study in Peruvian population].
    Colarossi A; Inga R; Prochazka R; Reyes U; Bussalleu A; Barúa RL
    Rev Gastroenterol Peru; 2011; 31(2):110-5. PubMed ID: 21836650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
    Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
    Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship between pepsinogen I/II ratio and age or upper gastrointestinal diseases in Helicobacter pylori-positive and -negative subjects].
    Paik CN; Chung IS; Nam KW; Kwon JH; Chang JH; Suh JP; Park JM; Cho YK; Lee IS; Kim SW; Choi MG
    Korean J Gastroenterol; 2007 Aug; 50(2):84-91. PubMed ID: 17928751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of impaired renal function and Helicobacter pylori infection on serum pepsinogen concentrations].
    Murakawa M
    Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):399-405. PubMed ID: 10441989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infections.
    Nurgalieva ZZ; Opekun AR; Graham DY
    Helicobacter; 2006 Apr; 11(2):69-74. PubMed ID: 16579835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
    Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in patients' symptoms and gastric emptying after Helicobacter pylori treatment.
    Zhang CL; Geng CH; Yang ZW; Li YL; Tong LQ; Gao P; Gao YQ
    World J Gastroenterol; 2016 May; 22(18):4585-93. PubMed ID: 27182168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normal serum pepsinogen I levels in adults: a population-based study with special reference to Helicobacter pylori infection and parietal cell antibodies.
    Hokkanen S; Kosunen TU; Sarna S; Miettinen A; Salomaa A; Aromaa A; Knekt P; Rautelin HI
    Scand J Clin Lab Invest; 2005; 65(4):291-9. PubMed ID: 16076684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening of precancerous gastric lesions by serum pepsinogen, gastrin-17, anti-helicobacter pylori and anti- CagA antibodies in dyspeptic patients over 50 years old in Guilan Province, north of Iran.
    Mansour-Ghanaei F; Joukar F; Rajpout Y; Hasandokht T
    Asian Pac J Cancer Prev; 2014; 15(18):7635-8. PubMed ID: 25292040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach.
    Parthasarathy G; Maroju NK; Kate V; Ananthakrishnan N; Sridhar MG
    Trop Gastroenterol; 2007; 28(4):166-70. PubMed ID: 18416347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum pepsinogen levels in the Japanese population: prospective study of 9 years of follow-up.
    Xie XF; Ito M; Yoshihara M; Haruma K; Tanaka S; Chayama K
    Hepatogastroenterology; 2007 Sep; 54(78):1887-90. PubMed ID: 18019741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Helicobacter pylori infection on esophagogastric variceal bleeding in patients with liver cirrhosis and portal hypertension.
    Sakamoto Y; Oho K; Toyonaga A; Kumamoto M; Haruta T; Inoue H; Emori K; Tsuruta O; Sata M
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1444-9. PubMed ID: 23577833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of bacterial CagA status on gastritis, gastric function indices, and pattern of symptoms in H. pylori-positive dyspeptic patients.
    Parente F; Imbesi V; Maconi G; Cucino C; Sangaletti O; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1998 Jul; 93(7):1073-9. PubMed ID: 9672333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum pepsinogen can predict response to H2-receptor antagonist in patients with functional dyspepsia.
    Yoshikawa I; Murata I; Kume K; Kanagawa K; Hirohata Y; Nakamura H; Otsuki M
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1805-9. PubMed ID: 12269975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.